SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 33.53-2.8%Nov 12 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bluegreen who wrote (16964)7/8/2004 9:02:45 AM
From: aknahow  Read Replies (1) of 17367
 
Every parent and Doctor should protest the way the FDA blocks something like Neuprex.

((("It's rather frustrating," says Elsbach, the researcher who is at the end of a career spent working on BPI. "I would agree with the FDA that they felt more information was necessary. But, you know, that is complicated by the fact that from what I could see looking at the data that if the agent had been available right on admission without delay, and I think Brett Giroir feels that way, that the results would have been quite convincing." )))

But sense the fear of even someone like Elsbach, of saying directly that the FDA was wrong!

The article makes me angry and a bit sick.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News